Q1 FY27 results: consolidated revenue down 44% YoY; PAT flat, board okays healthcare push
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts more than Nifty Microcap 250 and 3.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q1 FY27 (ended 30 June 2026): standalone revenue fell to Rs 25.05 lakh from Rs 40 lakh YoY; PAT Rs 14.31 lakh. Consolidated revenue dropped 44% to Rs 2,307.29 lakh from Rs 4,147.91 lakh; PAT flat at Rs 224.34 lakh. EPS Rs 0.01 standalone and Rs 0.08 consolidated. Board approved expanding objects clause into healthcare, hospitals, medical devices. One new independent director appointed, three re-appointed for 5 years. 35th AGM on 16 September 2026.
Sharp revenue decline signals a weak quarter; healthcare expansion plan could be a long-term positive but adds execution risk.